Skip to content
stoqly

Brookdale Senior Living Inc.

BKD NYSE Services-Nursing & Personal Care Facilities Financials FY2016–FY2025

Revenue Total sales reported in the income statement.
$3.2B
2.2% vs prior year
Operating margin Operating income as a share of revenue.
0.4%
1.1 pts
Net income Profit after all expenses, interest and tax.
βˆ’$263M
Free cash flow Cash from operations minus capital spending.
$16.5M
Return on capital After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
0.3%
0.7 pts
Market cap Last close times the latest diluted share count, so it is approximate.
β€”
P/E Last close divided by diluted earnings per share over the last four quarters.
β€”
On βˆ’$0.59 EPS (TTM)

What Brookdale Senior Living Inc. does

No business description yet.

Legal name
Brookdale Senior Living Inc.
Fiscal year ends
December 31, 2025
Latest annual report
10-K Β· Feb 19, 2026
Accession Β· CIK
0001332349-26-000032
0001332349

Revenue and margins

Brookdale Senior Living Inc. had $3.2B of revenue in fiscal 2025, up 2.2% on the year before.

Revenue
Revenue
Margins, % of revenue
Gross Operating Net FCF
Margins, % of revenue
Gross Operating Net FCF

Net income and earnings per share

Loss periods are shown in red.

Net income
Net income
Diluted EPS
Diluted EPS

Returns on capital

After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.

Return on capital, equity and assets (annual)
Return on capital Return on equity Return on assets

Cash flow

Free cash flow was $16.5M in fiscal 2025, 0.5% of revenue. Cash from operations minus capital spending.

Free cash flow
Free cash flow
Cash from operations vs capital spending
Cash from operations Capital spending
Cash from operations vs capital spending
Cash from operations Capital spending

Dividends, buybacks and share count

Brookdale Senior Living Inc. returned β€” to shareholders in fiscal 2025. The diluted share count rose 3.4%.

Dividends and buybacks
Dividends Buybacks
Diluted shares outstanding (annual)

Balance sheet

Cash, debt and the ratios that show how comfortably Brookdale Senior Living Inc. can carry it.

Cash vs debt (incl. leases)
Cash Debt
Fiscal year endFY21FY22FY23FY24FY25
Cash and short-term investments $529M$448M$308M$329M$279M
Debt incl. finance leases $4.4B$4.1B$3.8B$4.4B$4.3B
Net debt / EBITDA 30.2x11.7x9.6x9.8x10.5x
Debt / equity 5.5x6.6x9.2x19.1xβ€”
Interest coverage βˆ’1.1xβˆ’0.2x0.1x0.2xβ€”
Current ratio 1.1x1.0x0.8x0.9x1.0x
Quick ratio 1.1x1.0x0.8x0.9x1.0x
Total assets $6.4B$5.9B$5.6B$6.3B$6.0B
Total liabilities $5.7B$5.4B$5.2B$6.1B$6.0B
Shareholders' equity $697M$583M$404M$212Mβˆ’$44.8M
Net debt (βˆ’ = net cash) $3.9B$3.7B$3.5B$4.0B$4.0B

Insider trades

Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.

Bought, 12 months

$0.0M

0 insiders

Sold, 12 months

$0.0M

0 insiders

Of sales under plans

β€”

$0.0M

No open-market insider trades in the last 12 months.

Piotroski F-score

Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.

TestFY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Net income is positive βœ• βœ• βœ• βœ• βœ“ βœ• βœ• βœ• βœ• βœ•
Cash from operations is positive βœ“ βœ“ βœ“ βœ“ βœ“ βœ• βœ“ βœ“ βœ“ βœ“
Return on assets rose β€” βœ• βœ• βœ“ βœ“ βœ• βœ• βœ“ βœ“ βœ•
Cash from operations exceeds net income βœ“ βœ“ βœ“ βœ“ βœ“ βœ“ βœ“ βœ“ βœ“ βœ“
Debt fell relative to assets β€” βœ• βœ“ βœ“ βœ• βœ• βœ• βœ• βœ“ βœ•
Current ratio rose β€” βœ• βœ“ βœ• βœ“ βœ• βœ• βœ• βœ“ βœ“
Share count didn't rise β€” βœ• βœ• βœ“ βœ“ βœ• βœ• βœ• βœ• βœ•
Gross margin rose β€” βœ• βœ• βœ• βœ“ βœ• βœ“ βœ“ βœ“ βœ“
Revenue rose relative to assets β€” βœ“ βœ“ βœ• βœ• βœ• βœ“ βœ“ βœ• βœ“
F-score β€” / 33 / 95 / 95 / 97 / 91 / 94 / 95 / 96 / 95 / 9
Accruals ratio βˆ’8.4%βˆ’11.2%βˆ’10.4%βˆ’7.1%βˆ’1.8%βˆ’0.1%βˆ’3.9%βˆ’6.1%βˆ’6.2%βˆ’7.8%
Altman Z'' βˆ’0.49βˆ’1.22βˆ’1.97βˆ’1.88βˆ’1.44βˆ’1.77βˆ’1.94βˆ’2.28βˆ’2.06βˆ’2.36

10 years of figures

US$ millions unless stated. Hover a ratio's name for its definition.

Download CSV
Fiscal yearFY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Income statement
Revenue $5.0B $4.7B $4.5B $4.1B $3.5B $2.8B $2.8B $3.0B $3.1B $3.2B
Gross profit $1.4B $1.3B $1.1B $877M $797M $501M $594M $747M $799M $838M
Operating income βˆ’$31.1M βˆ’$270M βˆ’$594M βˆ’$44.5M βˆ’$97.7M βˆ’$217M βˆ’$42.7M $18.4M $46.5M $13.5M
Interest expense $386M $326M $280M $248M $209M $195M $205M $238M $253M β€”
Pretax income βˆ’$399M βˆ’$588M βˆ’$578M βˆ’$271M $87.3M βˆ’$108M βˆ’$240M βˆ’$180M βˆ’$197M βˆ’$265M
Income tax $5.4M βˆ’$16.5M βˆ’$49.5M βˆ’$2.3M $5.4M βˆ’$8.2M βˆ’$1.6M $8.8M $4.6M βˆ’$2.0M
Net income βˆ’$404M βˆ’$571M βˆ’$528M βˆ’$268M $82.0M βˆ’$99.3M βˆ’$238M βˆ’$189M βˆ’$202M βˆ’$263M
Diluted EPS βˆ’$2.18 βˆ’$3.07 βˆ’$2.82 βˆ’$1.44 $0.44 βˆ’$0.54 βˆ’$1.25 βˆ’$0.84 βˆ’$0.89 βˆ’$1.12
Diluted shares 0.19B 0.19B 0.19B 0.19B 0.18B 0.18B 0.19B 0.23B 0.23B 0.24B
Cash flow
Cash from operations $374M $378M $204M $216M $206M βˆ’$94.6M $3.3M $163M $166M $218M
Capital expenditure $334M $214M $225M $304M $186M $177M $197M $233M $201M $202M
Free cash flow $40.0M $164M βˆ’$21.5M βˆ’$87.7M $19.8M βˆ’$271M βˆ’$194M βˆ’$70.3M βˆ’$35.1M $16.5M
Depreciation and amortization $530M $495M $456M $384M $365M $345M $354M $350M $368M $370M
Stock-based compensation $32.3M $27.8M $26.1M $23.0M $20.7M $16.3M $14.5M $12.0M $14.2M $11.9M
Acquisitions $12.2M $5.2M β€” β€” β€” β€” β€” β€” β€” β€”
Share buybacks $9.6M $0.0M $4.3M $24.0M $18.1M $0.0M $0.0M β€” β€” β€”
Dividends and buybacks $9.6M $0.0M $4.3M $24.0M $18.1M $0.0M $0.0M β€” β€” β€”
Balance sheet
Cash and short-term investments $216M $514M $413M $309M $553M $529M $448M $308M $329M $279M
Total debt $6.0B $5.1B $3.6B $3.6B $3.9B $3.8B $3.9B $3.7B $4.1B $4.3B
Finance lease liabilities β€” β€” β€” $835M $563M $554M $249M $152M $304M $25.6M
Current assets $620M $902M $774M $596M $774M $699M $637M $478M $513M $554M
Current liabilities $731M $1.1B $773M $1.0B $691M $632M $641M $600M $580M $568M
Property and equipment, net $7.4B $5.9B $5.3B β€” β€” β€” β€” β€” β€” β€”
Goodwill $705M $506M $154M $154M $154M $27.3M $27.3M $27.3M $27.3M $27.3M
Intangible assets $83.0M $68.0M $51.5M $35.2M $34.1M β€” β€” β€” β€” β€”
Total assets $9.2B $7.7B $6.5B $7.2B $6.9B $6.4B $5.9B $5.6B $6.3B $6.0B
Total liabilities $7.1B $6.1B $5.4B $6.5B $6.1B $5.7B $5.4B $5.2B $6.1B $6.0B
Preferred stock $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M
Shareholders' equity $2.1B $1.5B $1.0B $696M $800M $697M $583M $404M $212M βˆ’$44.8M
Margins
Gross margin 28.9% 26.4% 23.6% 21.6% 22.5% 18.2% 21.0% 24.8% 25.6% 26.2%
Operating margin βˆ’0.6% βˆ’5.7% βˆ’13.1% βˆ’1.1% βˆ’2.8% βˆ’7.9% βˆ’1.5% 0.6% 1.5% 0.4%
EBITDA margin 10.0% 4.7% βˆ’3.1% 8.4% 7.6% 4.6% 11.0% 12.2% 13.2% 12.0%
Net margin βˆ’8.1% βˆ’12.0% βˆ’11.7% βˆ’6.6% 2.3% βˆ’3.6% βˆ’8.4% βˆ’6.3% βˆ’6.5% βˆ’8.2%
FCF margin 0.8% 3.5% βˆ’0.5% βˆ’2.2% 0.6% βˆ’9.8% βˆ’6.9% βˆ’2.3% βˆ’1.1% 0.5%
Returns
Return on capital βˆ’0.3% βˆ’3.5% βˆ’11.1% βˆ’0.9% βˆ’2.2% βˆ’4.3% βˆ’0.8% 0.4% 0.9% 0.3%
Return on capital employed βˆ’0.4% βˆ’4.1% βˆ’10.4% βˆ’0.7% βˆ’1.6% βˆ’3.8% βˆ’0.8% 0.4% 0.8% 0.3%
Return on equity βˆ’19.5% βˆ’31.7% βˆ’41.4% βˆ’31.2% 11.0% βˆ’13.3% βˆ’37.3% βˆ’38.3% βˆ’65.5% βˆ’313.2%
Return on assets βˆ’4.4% βˆ’6.8% βˆ’7.5% βˆ’3.9% 1.2% βˆ’1.5% βˆ’3.9% βˆ’3.3% βˆ’3.4% βˆ’4.3%
Return on tangible equity βˆ’31.4% βˆ’59.7% βˆ’65.0% βˆ’52.8% 13.4% βˆ’14.8% βˆ’42.9% βˆ’50.2% βˆ’109.1% β€”
Growth
Revenue growth β€” βˆ’4.6% βˆ’4.5% βˆ’10.5% βˆ’12.7% βˆ’22.1% 2.4% 6.7% 3.6% 2.2%
Net income growth β€” β€” β€” β€” β€” βˆ’221.1% β€” β€” β€” β€”
EPS growth β€” β€” β€” β€” β€” βˆ’222.7% β€” β€” β€” β€”
FCF growth β€” 311.1% βˆ’113.1% β€” β€” βˆ’1,471.7% β€” β€” β€” β€”
Share count change β€” 0.3% 0.7% βˆ’0.8% βˆ’0.8% 0.3% 3.0% 18.2% 1.0% 3.4%
Financial health
Net debt / EBITDA 11.7x 20.6x β€” 12.0x 14.7x 30.2x 11.7x 9.6x 9.8x 10.5x
Debt / equity 2.9x 3.4x 3.6x 5.1x 4.9x 5.5x 6.6x 9.2x 19.1x β€”
Interest coverage βˆ’0.1x βˆ’0.8x βˆ’2.1x βˆ’0.2x βˆ’0.5x βˆ’1.1x βˆ’0.2x 0.1x 0.2x β€”
Current ratio 0.8x 0.8x 1.0x 0.6x 1.1x 1.1x 1.0x 0.8x 0.9x 1.0x
Quick ratio 0.8x 0.8x 1.0x 0.6x 1.1x 1.1x 1.0x 0.8x 0.9x 1.0x
Capital allocation
Capex / revenue 6.7% 4.5% 5.0% 7.5% 5.3% 6.4% 7.0% 7.7% 6.4% 6.3%
Stock comp / revenue 0.6% 0.6% 0.6% 0.6% 0.6% 0.6% 0.5% 0.4% 0.5% 0.4%
Payouts / FCF 24.1% 0.0% β€” β€” 91.6% β€” β€” β€” β€” β€”
Quality scores
Piotroski F-score β€” 3.0 5.0 5.0 7.0 1.0 4.0 5.0 6.0 5.0
Altman Z'' βˆ’0.5 βˆ’1.2 βˆ’2.0 βˆ’1.9 βˆ’1.4 βˆ’1.8 βˆ’1.9 βˆ’2.3 βˆ’2.1 βˆ’2.4
Accruals ratio βˆ’8.4% βˆ’11.2% βˆ’10.4% βˆ’7.1% βˆ’1.8% βˆ’0.1% βˆ’3.9% βˆ’6.1% βˆ’6.2% βˆ’7.8%

Source: SEC EDGAR XBRL filings (CIK 0001332349). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β€” not investment advice. Check the original filings before relying on any figure.

↑ ↓ to move Β· ↡ to open